Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 77

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 77
---
90 days after the initial existence of the condition, (y) the grounds for termination (if susceptible to correction) are not corrected by us within 30 days of our receipt of such notice and (z) the termination date occurs within one year following our receipt of such notice. Under the employment agreements, a “change of control” means: (i) a merger or consolidation of either us or our subsidiary, Pacira Pharmaceuticals, Inc., a California corporation (“PPI-California”) into another entity in which the stockholders of us or PPI-California (as applicable) do not control 50% or more of the total voting power of the surviving entity (other than a reincorporation merger); (ii) the sale, transfer, or other disposition of all or substantially all of our assets in a liquidation or dissolution; or (iii) the sale or transfer of more than 50% of our outstanding voting stock. In the case of each of the foregoing clauses (i), (ii) and (iii), a “change of control” as a result of a financing transaction entered into by us or PPI-California shall not constitute a “change of control” for purposes of these employment agreements. POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL Below is a summary of the potential payments that each of our named executive officers would have received upon the occurrence of the termination events specified below, assuming that each triggering event occurred on December 31, 2024. David Stack and Charles A. Reinhart, III are not included in these tables because neither were employed by the Company as an executive officer as of December 31, 2024. Each of Mr. Stack’s payments in connection with his retirement from the Company and Mr. Reinhart’s payments in connection with his departure from the Company are described below. I. INVOLUNTARY TERMINATION WITHOUT CAUSE OR RESIGNATION FOR GOOD REASON

| Name             | ​ | ​ | Severance($) |   |           |   | ​ | ​ | HealthBenefits($) |   |        |   | ​ | ​ | Acceleration ofEquity Awards(1)($) |   |         |   | ​ | ​ | Total($) |   |           |   | ​ |
| Frank Lee        | ​ | ​ | ​            | ​ | 2,700,000 | ​ | ​ | ​ | ​                 | ​ | 28,645 | ​ | ​ | ​ | ​                                  | ​ | 468